Purpose With increasing attention on sustainable development, the environmental and social relevance of palm oil production are now important trade issues. The life cycle assessment (LCA) study of Malaysian oil palm products from mineral soils including palm biodiesel was aimed to provide baseline information on the environmental performance of the industry for drawing up policies pertaining to the sustainable production. The share of greenhouse gas (GHG) contribution by the various subsystems in the oil palm supply chain is considered here. Materials and methods The life cycle inventory data for the study were collected based on subsystems, i.e., gate-to-gate. The subsystems include activities in oil palm nurseries and plantations, palm oil mills, refineries, biodiesel plants and the use of biodiesel in diesel engine vehicles. Two scenarios were considered: extraction of crude palm oil (CPO) in a mill without and with a system for trapping biogas from palm oil mill effluent (POME). Inventory data were collected through questionnaires. On-site visits were carried out for data verification. Background data for resource exploitation and production of input materials were obtained through available databases and literature. Foreground data for all subsystems were site-specific data from nurseries, plantations, palm oil mills and refineries and biodiesel plants in Malaysia. Results and discussion Using a yield of 20.7 t oil palm fresh fruit bunches (FFB)/ha, the results showed that the production of 1 t of FFB produced 119 kg CO 2 eq. The production of 1 t of CPO in a mill without and with biogas capture emitted 971 and 506 kg CO 2 eq, respectively. For the production of 1 t of refined palm oil in a refinery which sourced the CPO from a mill without biogas capture and with biogas capture, the GHG emitted was 1,113 kg and 626 kg CO 2 eq, respectively. For palm biodiesel, 33.19 and 21.20 g CO 2 eq were emitted per MJ of biodiesel produced from palm oil sourced from a mill without and with biogas capture, respectively. Conclusions GHG contribution by the nursery subsystem was found to be minimal. In the plantation subsystem, the major sources of GHG were from nitrogen fertilizers, transport and traction energy. For the mill, biogas from POME was the major contributor if biogas was not trapped. Excluding contribution from upstream activities, boiler fuel and transport were the major sources of GHG in the refinery subsystem. In the biodiesel subsystem, activities for production of refined palm oil and methanol use were the most significant contributors.
Waste from agricultural products represents a disposal liability, which needs to be addressed. Palm oil is the most widely traded edible oil globally, and its production generates 85 million tons of aqueous by-products annually. This aqueous stream is rich in phenolic antioxidants, which were investigated for their composition and potential in vitro biological activity. We have identified three isomers of caffeoylshikimic acid as major components of oil palm phenolics (OPP). The 2,2-diphenyl-1-picrylhydrazyl assay confirmed potent free radical scavenging activity. To test for possible cardioprotective effects of OPP, we carried out in vitro LDL oxidation studies as well as ex vivo aortic ring and mesenteric vascular bed relaxation measurements. We found that OPP inhibited the Cu-mediated oxidation of human LDL. OPP also promoted vascular relaxation in both isolated aortic rings and perfused mesenteric vascular beds pre-contracted with noradrenaline. To rule out developmental toxicity, we performed teratological studies on rats up to the third generation and did not find any congenital anomalies. Thus, these initial studies suggest that OPP is safe and may have a protective role against free radical damage, LDL oxidation and its attendant negative effects, as well as vascular constriction in mitigating atherosclerosis. Oil palm vegetation liquor thus represents a new source of phenolic bioactives.
Valorisation of palm by‐products increases business opportunities for stakeholders in the palm oil industry. The approach also paves the way for structuring an eco‐efficient industry that recognises the importance of sustainable development for continued growth and competitiveness. Research underway in the palm oil industry has revealed a range of bioactives that can be used as functional components for food products that enhance health. Crude palm oil with 500–700 mg/kg of carotenes is one of the richest plant sources of provitamin A. Tocopherols and tocotrienols are also present in the oil at significant levels of between 600 and 1000 mg/kg. Besides the oil, by‐products of palm oil milling and refining also contain bioactives. Tocopherols and tocotrienols are concentrated in the palm fatty acid distillate (PFAD), a by‐product of physical refining of palm oil. Sterols and squalene can also be recovered from PFAD. Palm pressed fibres contain extractable phytochemicals such as sterols, vitamin E, carotenoids, phospholipids, squalene and phenolics. Water‐soluble palm phenolics have been successfully extracted from aqueous by‐products generated from the mill. These palm extracts show superior antioxidant potential and are earmarked for applications in functional foods, nutraceuticals, pharmaceuticals and cosmeticeuticals.
It is well established that plant phenolics elicit various biological activities, with positive effects on health. Palm oil production results in large volumes of aqueous by-products containing phenolics. In the present study, we describe the effects of oil palm phenolics (OPP) on several degenerative conditions using various animal models. OPP reduced blood pressure in a NO-deficient rat model, protected against ischaemia-induced cardiac arrhythmia in rats and reduced plaque formation in rabbits fed an atherogenic diet. In Nile rats, a spontaneous model of the metabolic syndrome and type 2 diabetes, OPP protected against multiple aspects of the syndrome and diabetes progression. In tumour-inoculated mice, OPP protected against cancer progression. Microarray studies on the tumours showed differential transcriptome profiles that suggest anti-tumour molecular mechanisms involved in OPP action. Thus, initial studies suggest that OPP may have potential against several chronic disease outcomes in mammals.
BackgroundPlant phenolics are important nutritional antioxidants which could aid in overcoming chronic diseases such as cardiovascular disease and cancer, two leading causes of death in the world. The oil palm (Elaeis guineensis) is a rich source of water-soluble phenolics which have high antioxidant activities. This study aimed to identify the in vivo effects and molecular mechanisms involved in the biological activities of oil palm phenolics (OPP) during healthy states via microarray gene expression profiling, using mice supplemented with a normal diet as biological models.ResultsHaving confirmed via histology, haematology and clinical biochemistry analyses that OPP is not toxic to mice, we further explored the gene expression changes caused by OPP through statistical and functional analyses using Illumina microarrays. OPP showed numerous biological activities in three major organs of mice, the liver, spleen and heart. In livers of mice given OPP, four lipid catabolism genes were up-regulated while five cholesterol biosynthesis genes were down-regulated, suggesting that OPP may play a role in reducing cardiovascular disease. OPP also up-regulated eighteen blood coagulation genes in spleens of mice. OPP elicited gene expression changes similar to the effects of caloric restriction in the hearts of mice supplemented with OPP. Microarray gene expression fold changes for six target genes in the three major organs tested were validated with real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR), and the correlation of fold changes obtained with these two techniques was high (R2 = 0.9653).ConclusionsOPP showed non-toxicity and various pleiotropic effects in mice. This study implies the potential application of OPP as a valuable source of wellness nutraceuticals, and further suggests the molecular mechanisms as to how dietary phenolics work in vivo.
ObjectivesPhenolics are important phytochemicals which have positive effects on chronic diseases, including neurodegenerative ailments. The oil palm (Elaeis guineensis) is a rich source of water-soluble phenolics. This study was carried out to discover the effects of administering oil palm phenolics (OPP) to mice, with the aim of identifying whether these compounds possess significant neuroprotective properties.MethodsOPP was given to BALB/c mice on a normal diet as fluids for 6 weeks while the controls were given distilled water. These animals were tested in a water maze and on a rotarod weekly to assess the effects of OPP on cognitive and motor functions, respectively. Using Illumina microarrays, we further explored the brain gene expression changes caused by OPP in order to determine the molecular mechanisms involved. Real-time quantitative reverse transcription-polymerase chain reaction experiments were then carried out to validate the microarray data.ResultsWe found that mice given OPP showed better cognitive function and spatial learning when tested in a water maze, and their performance also improved when tested on a rotarod, possibly due to better motor function and balance. Microarray gene expression analysis showed that these compounds up-regulated genes involved in brain development and activity, such as those under the regulation of the brain-derived neurotrophic factor. OPP also down-regulated genes involved in inflammation.DiscussionThese results suggest that the improvement of mouse cognitive and motor functions by OPP is caused by the neuroprotective and anti-inflammatory effects of the extract.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.